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It has become evident that mechanical forces play a key role in cancer metastasis, a com-
plex series of steps that is responsible for the majority of cancer-related deaths. One
such force is fluid shear stress, exerted on circulating tumor cells by blood flow in the
vascular microenvironment, and also on tumor cells exposed to slow interstitial flows in
the tumor microenvironment. Computational and experimental models have the potential
to elucidate metastatic behavior of cells exposed to such forces. Here, we review the
fluid-generated forces that tumor cells are exposed to in the vascular and tumor microenvi-
ronments, and discuss recent computational and experimental models that have revealed
mechanotransduction phenomena that may play a role in the metastatic process.
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INTRODUCTION
To initiate the metastatic spread of cancer through the blood-
stream, tumor cells must transit through microenvironments of
dramatically varying physical forces. Cancer cells must be able to
migrate through the stroma, intravasate through the endothelium
into blood or lymphatic vessels, flow within the vessels and sub-
sequently extravasate through the endothelium, and migrate and
colonize in tissue at a secondary site (Chambers et al., 2002; Steeg,
2006; Chaffer and Weinberg, 2011). In soft tissues, cancer cells are
exposed to mechanical forces due to fluid shear stress, hydrosta-
tic pressure, and tension and compression forces (Butcher et al.,
2009; DuFort et al., 2011). During intravasation and extravasa-
tion, cells undergo dramatic elastic deformations to transmigrate
through endothelial cell–cell junctions (Tseng et al., 2004; Wirtz
et al., 2011). Once in the circulation, tumor cells must be able to
withstand immunological stress, blood cell collisions, and hemo-
dynamic shear forces, while also utilizing flow to adhere to the
endothelial wall and subsequently extravasate to form a secondary
tumor (Hughes and King, 2011). Across all of these steps, a deeper
understanding is needed of how biophysical forces contribute
to biochemical changes in cancer cells, which can reveal novel
strategies in the treatment of metastasis.
Fluid shear stress is one of the prominent forces that cells
are exposed to, and its effects on blood cells, endothelial cells,
smooth muscle cells (SMCs), and others have been extensively
studied (Moazzam et al., 1997; Civelek et al., 2002; Li et al.,
2005). However, much less is known about fluid shear stress
effects on tumor cells. Cancer cells experience two main types
of fluid shear stress: stresses generated by blood flow in the vas-
cular microenvironment, and those generated by interstitial flows
in the tumor microenvironment (Michor et al., 2011; Swartz and
Lund, 2012). Stresses generated by interstitial and blood flows
could contribute to the metastatic process by enhancing tumor
cell invasion and circulating tumor cell (CTC) adhesion to blood
vessels, respectively. However, it is difficult to predict tumor cell
behavior to such forces; it is difficult to experimentally measure
such flows in the tumor microenvironment (Shieh and Swartz,
2011), and there is a general lack of data on force-dependent
CTC receptor–ligand interactions with the endothelium (Cheung
et al., 2011). Sophisticated experimental techniques coupled with
computational modeling are needed to predict cell behavior upon
exposure to varying complex physical forces.
In this review, we provide examples of both experimental and
computational methods to model and predict how cancer cells
respond to fluid shear forces. We begin by describing the fluid shear
forces that cancer cells are exposed to in both the tumor and vascu-
lar microenvironments, generated mainly by blood and interstitial
flows. An overview is provided on computational modeling to
estimate the forces exerted on cells in blood and tissues, along
with simulations to predict cell behavior under such flows. We
then describe recent cancer cell mechanotransduction phenom-
ena upon exposure to fluid shear stress, such as altering cancer cell
resistance to fluid shear stress, sensitivity to apoptosis-inducing
ligands, and invasive and migratory potential. We conclude with
current computational models that aim to integrate fluid shear
forces with chemical signaling, such as the effect of the glycocalyx
on transmitting physical forces and inducing mechanotransduc-
tion in cancer cells, as well as the integration of signal transduction
networks into adhesive dynamics (AD) simulations to predict cell
adhesion in the microvasculature.
FLUID SHEAR STRESS EXPOSURE IN THE TUMOR
MICROENVIRONMENT
Cancer cells in the tumor microenvironment are exposed to mul-
tiple physical forces including fluid shear stress, hydrostatic pres-
sure, tension, and compression, which have been treated in detail
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previously (Butcher et al., 2009;Wirtz et al., 2011; Swartz and Lund,
2012). Here, cancer cell exposure to physical forces generated by
interstitial flows will be discussed briefly.
Interstitial flow is the slow movement of fluid around cells and
through the pores of the extracellular matrix (ECM) that com-
prise the interstitium (Figure 1A). One of the main functions of
interstitial flow is lymphatic drainage, which returns plasma from
leaky capillaries back to the bloodstream. Drainage occurs due
to Starling’s forces, which are osmotic and hydrostatic pressure
gradients between blood vessels, interstitium, and the lymphatics
(Schmid-Schonbein, 1990). The composition of interstitial fluid
can vary depending on the location in the body, but in soft tissues
is generally similar to the blood plasma that leaks from capillar-
ies, and contains approximately 40% of the protein concentration
of plasma (Swartz and Fleury, 2007). The velocities of interstitial
flows are believed to range from 0.1 to 1.0µm s−1 in normal tis-
sues (Chary and Jain, 1989; Dafni et al., 2002). Cell surface shear
stresses are believed to be on the order of 0.1 dyn cm−2 (Pedersen
et al., 2007; Tarbell and Shi, 2012).
Interstitial flows can be elevated significantly in the tumor
microenvironment, and play a crucial role in tumor progression.
Chary and Jain (1989) utilized fluorescence recovery after photo-
bleaching (FRAP) to measure interstitial fluid velocities of bovine
serum albumin in normal and neoplastic tissues. Harrell et al. uti-
lized live imaging of tumor-bearing mice to measure downstream
lymph flow via injection of fluorescent nanoparticles. Measure-
ments were performed in both normal and neoplastic tissues;
all tumor-bearing mice in the study showed increases in lymph
flow, compared to control mice without tumors (Harrell et al.,
2007).
Elevated interstitial flows in the tumor microenvironment are
likely due to increased tumor interstitial fluid pressure (IFP).
Boucher and Jain (1992) implanted colon adenocarcinoma cells
into mice, tracked the development of the tumor vasculature using
intravital microscopy, and measured IFP using micropipettes and
a servo-null system. IFP measurements increased significantly as
the vasculature developed, demonstrating that tumor interstitial
FIGURE 1 | Cancer cell exposure to the tumor and vascular
microenvironments. (A) Tumor cell exposed to interstitial flow in a
collagen matrix (Swartz and Fleury, 2007). (B) Circulating tumor cell (CTC)
exposed to fluid shear forces in a blood vessel.
hypertension is associated with tumor angiogenesis (Boucher et al.,
1996). IFP is elevated in a uniform manner throughout tumors,
and drops significantly at the tumor periphery (Boucher et al.,
1990). Thus, IFP gradients facilitate fluid flow outward from
tumors, presenting a mass transport barrier for the delivery of
chemotherapeutics (Netti et al., 1995; Lunt et al., 2008).
Increased IFP also effects tumor biology, as it applies increased
physical force to the ECM and alters interstitial flows that
the tumor and surrounding cells are exposed to. Nearby lym-
phatic vessels respond to elevated interstitial flow by upregulating
chemokine CCL21 expression, along with cell adhesion molecules
E-selectin and ICAM-1 (Miteva et al., 2010). Secretion of CCL21
directs tumor cells toward lymphatic vessels (Shields et al., 2006),
while ICAM-1 and E-selectin upregulation enhances cell transmi-
gration into lymphatic vessels (Johnson et al., 2006; Miteva et al.,
2010). Lymph nodes can also be affected, as increased intersti-
tial flows aid in lymph node architecture remodeling to colonize
tumor cells, as well as protect the tumor from an immune response
(Shieh and Swartz, 2011).
Fibroblasts, which deposit, turn over, and remodel ECM to
maintain connective tissue homeostasis, can aid in tumor pro-
gression due to elevated interstitial flows. Elevated interstitial
flows can upregulate transforming growth factor beta-1 (TGF-
β1) expression (Ng et al., 2005; Ng and Swartz, 2006; Wipff et al.,
2007; Ahamed et al., 2008), which can induce a tumor-associated
fibroblast phenotype characterized by enhanced contractility and
increased secretion of cytokines, angiogenic growth factors, and
matrix metalloproteinase (MMPs) (Hinz et al., 2002; De Wever
et al., 2004a,b; Orimo and Weinberg, 2006). Recently, Shieh et al.
(2011) demonstrated that interstitial flows can enhance tumor cell
invasion when cocultured with dermal fibroblasts in a 3D colla-
gen matrix. Fibroblast invasion was enhanced due to increased
expression of TGF-β (Chaffer and Weinberg, 2011) and MMPs,
while it appeared that tumor cell invasion was enhanced due to
fibroblast-dependent remodeling of the ECM (Shieh et al., 2011).
FLUID SHEAR STRESS EXPOSURE IN VASCULAR
MICROENVIRONMENT
To enter the vascular microenvironment, cancer cells penetrate
surrounding tissue and enter nearby blood and lymphatic vessels
in a process called intravasation. The underlying mechanisms that
govern intravasation are not well understood; it is still in question
whether intravasation is an active or passive process (Bockhorn
et al., 2007), and whether tumor cells enter the circulation via
endothelial cell-cell junctions or directly through endothelial cells
themselves (Khuon et al., 2010). Regardless of their mechanism of
entry, cancer cells are exposed to a new set of conditions once in
the vascular microenvironment, including immunological stress,
collisions with blood cells, and hemodynamic shear forces, all of
which can affect their survival and proliferation.
Cancer cells are primarily exposed to erythrocytes, leukocytes,
and platelets upon entering the bloodstream,as studies have shown
that the concentration of cancer cells in the blood of patients is on
the order of one in a million leukocytes (Maheswaran and Haber,
2010), or one in a billion blood cells (Yu et al., 2011). Exposure
to such cells can lead to immunological stresses and blood cell
collisions that can affect cancer cell viability (Wirtz et al., 2011),
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although there is evidence that the association of platelets with
cancer cells in the bloodstream can promote tumor metastasis
(McCarty et al., 2000; Gay and Felding-Habermann, 2011).
Cancer cells are also exposed to hemodynamic shear forces
in the bloodstream (Figure 1B), which range from 0.5 to
4.0 dyn cm−2 in the venous circulation and 4.0–30.0 dyn cm−2 in
arterial circulation (Turitto, 1982). Shear rates can range from
approximately 160 s−1 in veins to 900 s−1 in arteries. Such shear
stresses and rates can affect cancer cell viability and thus the
chances of metastasis. For example, B16 melanoma cell expo-
sure to fluid shear stress in a cone-and-plate viscometer at shear
rates greater than 300 s−1 induced a significant loss of cell viability
(Brooks, 1984).
In contrast, fluid shear stress is an essential component of
cancer metastasis, as it is critical for cancer cell adhesion to the
endothelial cell wall and subsequent extravasation into tissues. A
variety of cancer cell lines are known to express sialylated carbo-
hydrate ligands, which adhesively interact with selectin proteins
on the inflamed microvasculature (Gout et al., 2008; Köhler et al.,
2010; Läubli and Borsig, 2010). Thus, cancer cells are believed to
undergo an adhesion cascade similar to leukocytes, which consists
of a sequence of steps involving tethering, rolling, and firm adhe-
sion to the endothelium (Chambers et al., 1995; Coussens and
Werb, 2002). Multiple studies have documented that a variety of
tumor cell lines bind to E-selectin proteins under physiological
shear stresses of the post-capillary venules (Giavazzi et al., 1993;
Barthel et al., 2009).
Much less is known about fluid shear stresses that cancer
cells could be exposed to in lymphatic vessels. Lymphatic vessels
have been stained with fluorescein isothiocyanate (FITC)-labeled
macromolecules to measure lymphatic flow in single lymphatic
capillaries of humans in vivo using intravital capillary microscopy
(Fischer et al., 1996). The recorded median linear velocity in lym-
phatic capillaries was 9.7µm s−1, and shear stresses in lymph node
sinuses have been estimated to be 10-fold lower than hematoge-
nous shear stresses (Resto et al., 2008). Despite the dramatic
decrease in shear stress levels, parallel plate flow chamber stud-
ies have shown that human head and neck squamous carcinoma
cells can bind to lymphocyte L-selectin at lymphatic shear stress
levels of 0.07–0.08 dyn cm−2 (Resto et al., 2008).
COMPUTATIONAL METHODS TO MODEL CELL EXPOSURE TO
INTERSTITIAL FLOWS
Interstitial flow mechanics were initially described by French
hydraulics engineer Henry Darcy, who studied the flow of water
through sand beds as a means of providing filtered drinking water





where K is the permeability of the medium, ∇P is the pressure
gradient vector, µ is the viscosity of the fluid, and u¯ is the aver-
aged velocity through the bulk. Darcy’s law works well when the
average velocity or mass flow rate needs to be determined, but
is first order with respect to velocity. To account for interstitial
flows between boundaries, Brinkman developed a second order
term, taking into account no-slip boundary conditions adjacent
to bounding walls (Figure 2A; Brinkman, 1949). The Brinkman




Permeability measurements have been performed for a variety
of tissues in vitro, in vivo, and ex vivo, including muscle (Rasheid
Zakaria et al., 1997), dermis (Bert and Reed, 1995), cartilage (Lev-
ick, 1987), tumors (Netti et al., 2000; McGuire et al., 2006), and
fibrin and collagen gels (Diamond, 1999; Ng and Swartz, 2003),
making the Darcy and Brinkman equations useful for both exper-
imental measurements of interstitial flows and computational
models of cells exposed to such flows.
Initial models of interstitial flows exerted on cells were devel-
oped for tissues including smooth muscle, cartilage, and bone
(Kwan et al., 1984; Grodzinsky et al., 2000; Hellmich and Ulm,
2005). For example, Wang and Tarbell (1995) modeled the tunica
media of an artery as a periodic array of cylindrical, imperme-
able SMCs embedded in a matrix consisting of collagen and
FIGURE 2 | Computational models of cells exposed to blood and
interstitial flows. (A) Computational models utilizing the Brinkman
equation to estimate interstitial flow-generated shear stresses on the cell
surface (Tarbell and Shi, 2012). u∞: velocity far from cell surface.
(B) Adhesive dynamics (AD) simulations to predict selectin-mediated
adhesion to the endothelium (Bhatia et al., 2003). u, velocity; R, cell radius;
sLex, sialyl-Lewis-x; ICAM-1, intercellular adhesion molecule-1.
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proteoglycans, and used Brinkman’s theory to model interstitial
flow across the tissue. The model was able to estimate the effective
hydraulic permeability of the tissue and shear stresses exerted on
SMCs, which were estimated to be on the order of 1.0 dyn cm−2
despite exposure to low interstitial flows (Wang and Tarbell,
1995). In an early model describing the mechanics of interstitial-
lymphatic transport, Swartz et al. developed a theoretical and
experimental model demonstrating how interstitial flow is depen-
dent on hydraulic conductivity, elasticity, and lymphatic conduc-
tance. They then utilized this model to examine fluid balance in
normal and chronically swollen (edematous conditions) mouse
tails, in which they found that remodeling of the matrix damp-
ened and eventually stagnated fluid movement in the case of edema
(Swartz et al., 1999).
COMPUTATIONAL METHODS TO MODEL CELL BEHAVIOR IN
THE CIRCULATION
A variety of computational methods have been developed to
model cell behavior in the vascular microenvironment, includ-
ing adhesive dynamics (AD), which has been utilized to simulate
cell adhesion to the endothelial cell surface under flow (Ham-
mer and Lauffenburger, 1987; Hammer and Apte, 1992). The
motivation of such simulations is to predict how adhesiveness
quantitatively depends on factors such as shear rate and viscosity,
which can reveal adhesion phenomena that might not necessar-
ily follow intuition. AD is a mechanically rigorous cell adhesion
simulation that models individual molecular bonds as compli-
ant springs. In the simulation, the cell can be modeled as a rigid
spherical particle covered with a random distribution of adhesion
molecules (Figure 2B). The endothelial cell wall can be modeled
as a surface covered with counter-receptor molecules of random
distribution. Bonds randomly form between adhesion molecules
of the cell and counter-receptors on the wall; these bonds can
then break contingent on the appropriate kinetics, which depend
on the instantaneous force loading on the spring endpoints. The
rates of bond formation and rupture can be calculated using the
Bell model for kinetics of single biomolecular bond failure (Bell,
1978; Bell et al., 1984):





where kr is the rate of dissociation, k0r is the unstressed off-rate,
F is the force on the bond, r0 is the reactive compliance, T is
the temperature, and kb is the Boltzmann constant. The rate of
bond formation follows from the Boltzmann distribution of affin-
ity, while also incorporating the effects of relative motion between
the cell and surface (King et al., 2005). To solve the algorithm,
unbound receptors in the defined contact area are first tested for
formation against the probability:
Pf = 1− exp
(−kf ∆t)
where Pf is the probability of bond formation, and t is time. Next,
bound receptors are tested for breakage against the probability:
Pr = 1− exp (−kr∆t )
where Pr is the probability of bond rupture. External forces and
torques on the cell are then summed, and a mobility calculation
determines the motion of the cell. Cell and bond positions are
updated based on the kinematics of cell motion. Torques exerted
by fluid flow and hydrodynamic forces cause the adherent cell to
slowly roll forward on a reactive surface. The motion of fluid is
governed by the Stokes equation:
µ∇2u = ∇P , ∇ · u = 0,
where u is the velocity, µ is the viscosity of the fluid, and P is
the pressure. No-slip boundary conditions are applied at the cell
surface and the planar wall.
While AD has not yet been used to model cancer cell adhe-
sion, many simulations have been performed using leukocytes,
which can be a close parallel to a CTC that has undergone the
epithelial-mesenchymal transition (EMT). Chang et al. (2000) uti-
lized AD to develop a state diagram for leukocyte adhesion under
flow. In the diagram, observed adhesive behaviors (rolling, firm
adhesion, or no adhesion) were plotted at given dissociation rates
and bond interaction lengths, which spanned several orders of
magnitude. Caputo and Hammer (2005) incorporated deformable
microvilli with clustered adhesion molecules onto the surface of
the simulated leukocyte, and found that the deformability of the
microvilli can affect the cell’s ability to roll on a surface. King and
Hammer (2001a,b) modeled the effect of cell–cell hydrodynamic
interactions on the dynamics of leukocyte adhesion using Multi-
particle AD (MAD), which revealed a mechanism for secondary
hydrodynamic recruitment of leukocytes to the blood vessel wall,
independent of leukocyte–leukocyte contact interactions.
Critical parameters of AD simulations are the kinetics of
selectin–carbohydrate bonds, as force-dependent dissociation
rates dictate the rolling adhesion of leukocytes. Numerous studies
have investigated the kinetics for leukocyte selectin ligands using
experimental techniques such as flow chamber tethering experi-
ments, atomic force microscopy, and dynamic force spectroscopy
(Smith et al., 1999). However, such kinetics for newly identified
selectin ligands expressed by metastatic tumor cells, which appear
distinct from those found on the surface of leukocytes (Thomas
et al., 2008; Shirure et al., 2012), have not yet been well charac-
terized. Future experimental studies measuring bond dissociation
kinetics for selectins and CTC selectin ligands will enable the devel-
opment of more predictive computational models of cancer cell
adhesion to microvasculature.
CURRENT EXPERIMENTAL MODELS OF CANCER CELL
MECHANOTRANSDUCTION
FLUID SHEAR STRESS ALTERS CANCER CELL RESPONSE TO
APOPTOSIS-INDUCING LIGANDS
The targeting and treatment of CTCs within the circulation is cur-
rently being investigated as an approach to prevent their metastatic
spread. For example, microfluidic devices coated with E-selectin
conjugated liposomal doxorubicin have been shown to capture
cancer cells from flow, deliver doxorubicin into the cell, and induce
cell death (Mitchell et al., 2012a,b). Similarly, microfluidic devices
immobilized with E-selectin and tumor necrosis factor (TNF)-
related apoptosis-inducing ligand (TRAIL) have been shown to
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capture and kill cancer cells (Rana et al., 2009) while exerting
minimal toxic effects on human leukocytes (Rana et al., 2012).
However, little is known about how fluid shear stress exposure can
affect cancer cell response to drug treatments.
Our recent study examined how colorectal adenocarcinoma
COLO 205 and prostate adenocarcinoma PC-3 cancer cell expo-
sure to physiologically relevant fluid shear stresses in a cone-
and-plate viscometer altered their response to TRAIL (Figure 3;
Mitchell and King, 2013). Experiments were devised in such a way
that fluid shear stress alone had negligible effects on cancer cell
death. Cancer cells were treated with both TRAIL, which can bind
to death receptors DR4 and DR5 on the cancer cell surface to initi-
ate apoptosis (Ashkenazi, 2002), and doxorubicin, which induces
cell death via inhibition of topoisomerase II and DNA intercalation
(Young et al., 1981; Osheroff et al., 1994). Interestingly, treatment
of both COLO 205 and PC-3 cancer cell lines with TRAIL followed
by exposure to 2.0 dyn cm−2 of fluid shear stress significantly
increased the number of apoptotic cells, compared to TRAIL-
treated cancer cells exposed to static conditions. The sensitization
effect was both fluid shear stress dose- and time-dependent, as
the number of apoptotic cells increased over a range of shear
stress magnitudes (0.05–2.0 dyn cm−2) and shear stress exposure
times (1–120 min). However, such sensitization was not evident
in doxorubicin treatment, as the percentage of apoptotic cells
remained nearly identical in doxorubicin-treated samples exposed
to either fluid shear stress or static conditions. The results indi-
cated that such sensitization could be receptor-mediated apoptosis
specific.
It is possible that death receptors on the cancer cell surface can
sense and respond to fluid shear forces. The idea of circulating
cells expressing mechanosensitive receptors has recently been
investigated in leukocytes (Makino et al., 2006; Mitchell and
King, 2012), where it is believed that G-protein coupled recep-
tors can sense fluid shear stress and alter neutrophil adhesion to
the microvasculature. However, little is known about the effects
of fluid shear stress on CTC surface receptors. Insight into the
mechanistic basis of such processes could reveal new strategies for
treating cancer cells in the circulation, and reducing the likelihood
of metastasis.
CANCER CELL RESISTANCE TO FLUID SHEAR STRESS
Recently, a microfluidic protocol was developed to assess can-
cer cell resistance to fluid shear stress (Barnes et al., 2012). In
the protocol, dilute cancer cell suspensions were drawn up into a
syringe, which was then loaded into an automatic syringe pump
(Figure 4A). Cancer cell suspensions were exposed to brief, mil-
lisecond pulses of high fluid shear stress as they were expelled
from the syringe pump, and subsequently analyzed for cell via-
bility using bioluminescent imaging. The maximum fluid shear
stress that cancer cells were briefly exposed to in this experi-
ment reached 6400 dyn cm−2. Note that CTCs are momentarily
exposed to shear stresses as high as 3000 dyn cm−2 at vessel bifur-
cations, in the heart, and near the walls of large blood vessels
(Strony et al., 1993; Malek et al., 1999). While cancer cell viability
decreased after repeated millisecond pulse exposures to high fluid
shear stress, the study revealed that cancer cells of epithelial origin
were surprisingly resistant to fluid shear stress, in comparison to
non-transformed epithelial cells. Resistance to fluid shear stress
was dependent on several oncogenes, as myc- and ras-transformed
cell lines showed an increase in fluid shear stress resistance. The
FIGURE 3 | Fluid shear stress sensitizes cancer cells to the
apoptosis-inducing ligandTRAIL. Colorectal adenocarcinoma COLO
205 cells exposed to non-shear conditions (A) and fluid shear stress
(B), respectively. COLO 205 cells treated with TRAIL and then
exposed to non-shear conditions (C) and fluid shear stress (D). Lower
left-hand and right-hand quadrants of each flow cytometry figure
represent viable cells and cells in early stages of apoptosis,
respectively. Upper left-hand and right-hand quadrants represent cells
undergoing necrosis and late stage apoptosis, respectively.
Percentage of viable (E) and apoptotic (F) COLO 205 cells after
treatment with TRAIL followed by exposure to non-shear or shear
conditions (n=3). Percentage of viable (G) and apoptotic (H) PC-3
cells treated under the same conditions (n=3). PE, phycoerythrin;
FITC, fluorescein isothiocyanate. Error bars represent 95%
confidence intervals. *P <0.05. **P <0.01. NS, non-significant.
Figure reprinted with permission from Mitchell and King (2012).
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FIGURE 4 | Experimental techniques to study cancer cell
mechanotransduction. (A) Microfluidic protocol to deliver millisecond
pulses of fluid shear stress to tumor cells (Barnes et al., 2012). Tumor cell
resistance to fluid shear stress determined using bioluminescent imaging
(BLI). (B) Darcy flow apparatus for the application of fluid shear stress in 3D
to tumor cells embedded in collagen (Qazi et al., 2011). Shear
stress-exposed cells are then placed in a modified Boyden chamber to
measure their migratory and invasive potential in the presence of TGF-α.
resistance response required extracellular calcium and actin poly-
merization, as the absence of calcium or treatment with EGTA,
cytochalasin D, or ROCK inhibitor Y27632 all reduced cancer cell
viability upon fluid shear stress exposure. In particular, extracellu-
lar calcium is important for cellular repair mechanisms based on
an extracellular calcium-dependent membrane resealing process
(Terasaki et al., 1997).
FLUID SHEAR STRESS REGULATES CANCER CELL INVASIVE POTENTIAL
Prior work has shown that the chemokine gradients generated by
interstitial flows can enhance tumor cell migration (Shields et al.,
2007), however it is not well understood whether fluid shear stress
can regulate intrinsic properties of cancer cells, thus altering their
invasive potential. Recent work by Qazi et al. (2011) detailed a
Darcy flow apparatus for the application of fluid shear stress to a
3D collagen gel embedded with glioma cells, coupled with a mod-
ified Boyden chamber invasion assay. In the apparatus, a double
reservoir system applied hydrostatic pressure, which drove media
throughout the 3D collagen gel and exerted shear stress on the
glioma cells (Figure 4B). Cancer cells were exposed to fluid shear
stresses ranging from 0.1 to 0.6 dyn cm−2. The media filtrate from
the gel was collected in a separate reservoir, and the media collected
was used to calculate flow rates, velocities, and shear stresses. Col-
lagen gels were removed at the end of the flow period, and placed
within modified Boyden chambers containing TGF-α to initiate
invasion assays.
Fluid shear stress significantly reduced U87 and CNS-1 glioma
cell migration by as much as 92% and 58% respectively, when
compared to controls. Migration suppression was not due to
flow-induced chemokine gradients, however, as cells were exposed
to fluid shear stress followed by exposure to TGF-α in static
Boyden chambers. Invasion was dependent on matrix metallo-
proteinases (MMPs), as MMP-1 and MMP-2 gene expression
was significantly downregulated in cancer cells upon exposure
to 0.55 dyn cm−2 fluid shear stress. Previous studies have shown
that fluid shear stress can affect MMP expression and activity
in non-tumor cell types such as fibroblasts, chondrocytes, and
SMCs (Yokota et al., 2003; Garanich et al., 2007; Shi and Tar-
bell, 2011), however this was one of first studies revealing that
fluid shear stress-induced mechanotransduction is involved in
interstitial flow-induced cancer cell motility.
INTERSTITIAL FLOW INDUCES TUMOR CELL FOCAL ADHESION KINASE
ACTIVATION
A recent study investigated two competing mechanisms which
can alter tumor cell migration upon exposure to interstitial flow:
an autologous chemotaxis-based mechanism which distributes
autocrine chemokine via convection to create a chemokine gra-
dient, and a mechanism whereby interstitial flow activates focal
adhesion kinase (FAK) and modulates forces critical for tumor cell
migration (Fincham and Frame, 1998; Sieg et al., 1998). Polacheck
et al. (2011) developed a microfluidic cell culture system to inves-
tigate the effects of interstitial flow on the directional bias and
dynamics of tumor cell migration in a 3D matrix. Utilizing two
channels separated by a region in which tumor cells were sus-
pended in a 3D collagen gel, a pressure gradient was applied across
the gel to generate consistent interstitial flow velocities ranging
from 0.3 to 3.0µm s−1, representative of a range of values mea-
sured in vivo (Dafni et al., 2002; Heldin et al., 2004). Confocal
reflective microscopy was used to track cell migration under flow,
and it was found that interstitial flow and cell seeding density can
both influence the direction of tumor cell migration.
Upon exposure to interstitial flow at low seeding densities,
MDA-MB-321 metastatic breast cancer cells migrated in the down-
stream direction, or “with the flow.” However, cancer cells exposed
to interstitial flow at high seeding densities migrated upstream,
or “against the flow.” Treatment with CCR7 blocking antibodies,
to block the binding of secreted ligand CCL21 needed to initi-
ate autologous chemotaxis, caused cells to shift their migration
directionality and migrated upstream upon exposure to flow. Cells
that migrated in the opposite direction of flow displayed increased
phosphorylation at Tyr-397 in FAK, which plays a role in Src kinase
activation and focal adhesion formation (Li et al., 1997; Jalali et al.,
1998). Upon blockage of Src kinase activity, upstream tumor cell
migration decreased and displayed random cell migration.
CURRENT ADVANCES IN MODELING
MECHANOTRANSDUCTION PHENOMENA
MODELING GLYCOCALYX EFFECTS ON INTERSTITIAL FLUID SHEAR
STRESS TRANSMISSION TO CANCER CELLS
The glycocalyx is a layer of proteoglycans and glycoproteins that
covers eukaryotic cells, which can serve as a mechanosensor of
fluid shear stress in endothelial cells and SMCs (Yao et al., 2007;
Shi et al., 2011). Tumor cells also possess a glycocalyx (Kräh-
ling et al., 2009), however its effects as a mechansensor have not
been previously investigated. It has been hypothesized that fluid
shear stress generated by interstitial flows is too weak to induce
mechanotransduction.
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Tarbell and Shi (2012) recently developed a computational
model to estimate the interstitial flow-generated fluid and solid
stresses on the surface of a glycocalyx-covered cell embedded
in ECM (Figure 5A). Previously estimated parameters such as
the Darcy permeability of the ECM, tumor cell glycocalyx thick-
ness, and interstitial fluid flow velocity were incorporated into
the model to calculate the fluid and solid stresses on the cell sur-
face. Brinkman equations were used to describe interstitial fluid
flow through pores of both the ECM and glycocalyx. A previ-
ously described model (Secomb et al., 2001) was used to calculate
mechanical equilibrium of forces in the direction of flow to cal-
culate the solid stresses transmitted via the glycocalyx. While fluid
stresses exerted on the tumor cell surface were estimated to be quite
low (less than 0.1 dyn cm−2), the solid stresses transmitted to the
cell via the glycocalyx were predicted to be over 5.0 dyn cm−2, a
magnitude which is known to activate endothelial cells (Malek
et al., 1999). Future models could incorporate mechanical effects
along with chemical signaling pathways to better predict cancer
cell mechanotransduction in tissues.
INTEGRATING SIGNAL TRANSDUCTION NETWORKS INTO ADHESIVE
DYNAMICS SIMULATIONS
Recently, signal transduction models were incorporated into AD
simulations to couple signaling pathways with cell adhesion. In
the model, leukocytes were assigned a random spatial distribution
of integrin lymphocyte function-associated antigen-1 (LFA-1), in
addition to selectin ligands such as PSGL-1. The reactive surfaces
were covered with selectin molecules and intracellular adhesion
molecule-1 (ICAM-1), which binds to active LFA-1 and mediates
firm arrest. Krasik et al. (2006) integrated the mitogen-activated
protein kinase (MAPK) signal transduction pathway as a modu-
lar Hill function within the AD framework to model neutrophil
arrest with deterministic activation. Selectin ligation triggered the
MAPK cascade in this model, which can cause inactive LFA-1 to
become activated, enabling binding to ICAM-1 and subsequent
neutrophil arrest. This model has since incorporated a stochas-
tic signal transduction model, utilizing a Monte Carlo simulation
within the microvilli of model neutrophils (Krasik et al., 2008).
Caputo et al. generated an AD simulation with an integrated
signal transduction network that incorporates selectin, integrin,
and chemokine interactions between the neutrophil and the sub-
strate. A random distribution of the G-protein coupled receptor
CXCR1 and chemokine interleukin-8 (IL-8) were displayed on the
leukocyte and the reactive surfaces, respectively (Figure 5B,C).
CXCR1 can interact with IL-8, which initiates a signaling cascade
leading to LFA-1 activation on the cell (Caputo and Hammer,
2009). Beste et al. (2012) developed a model of T-lymphocyte
arrest by combining AD with a kinetic model for chemokine-
triggered inside-out integrin activation. The model incorporated
signaling data measured in experiments to simulate the time scale
for T-lymphocyte arrest, and provided a predictive simulation for
understanding chemokine control of T-lymphocyte recruitment.
FIGURE 5 | Advances in computational modeling reveal
mechanotransduction phenomena. (A) Interstitial flow models
incorporating the force-transducing cell glycocalyx to determine
interstitial flow contributions to fluid shear stress-dependent
mechanotransduction (Tarbell and Shi, 2012). u∞, velocity far from cell
surface; K m, matrix Darcy permeability; K g, glycocalyx Darcy
permeability; H, glycocalyx layer thickness; ug∞, velocity profile in
glycocalyx; τw, surface fluid stress; τwg, surface solid stress.
(B,C) Incorporation of cell signaling networks to predict flow-mediated
cell adhesion in the presence of chemoattractants (Caputo and Hammer,
2009). IL-8, interleukin-8; PSGL-1, P-selectin glycoprotein ligand-1; LFA-1,
lymphocyte function-associated antigen-1.
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The integration of signal transduction networks into AD sim-
ulations could prove particularly useful for the study of cancer
metastasis, as molecular defects could be implemented within the
signaling cascade to predict its effects on CTC adhesion to the
endothelium.
COMPUTATIONAL MODELS OF INTEGRIN–LIGAND INTERACTIONS AT
THE CELL-ECM INTERFACE
A model based on the AD simulation was developed to both chem-
ically and mechanically model integrin dynamics at the cell-ECM
interface (Paszek et al., 2009). Paszek et al. developed the model to
determine whether the cell glycocalyx and the chemical and phys-
ical parameters of the ECM can control the formation of integrin
clusters, which act as mechanical anchors and can regulate cell sur-
vival, motility, differentiation, and morphogenesis (Hynes, 2002;
Miranti and Brugge, 2002; Berrier and Yamada, 2007). Integrin–
ligand bonds were modeled as individual Hookean springs, and
the Bell model was utilized to calculate kinetic rates of bond for-
mation and rupture, which are distance-dependent (Bell, 1978;
Bell et al., 1984). In addition, the model included a lattice spring
model (LSM) of the cell–ECM interface, consisting of a lattice of
interconnecting nodes and springs to calculate the stress–strain
behavior of the interface (Ostoja-Starzewski et al., 1996). Model
parameters including the glycocalyx, membrane, and bond spring
constants, on- and off-rates, and receptor and ligand density were
estimated based on experimental measurements.
Integrin clustering began as a fast process, as simulations
showed that new integrin bond formation events were more likely
to occur near existing integrin bonds where the separation dis-
tance between integrins and ligands was reduced. However, bond
rearrangements due to bond breakage and reformation were found
to slow down the integrin clustering process over time. Glycocalyx
thickness also affected integrin clusters, with larger, denser clus-
ters forming with increased glycocalyx thickness. The interplay
between integrin–ligand affinity and cell–ECM repulsion due to
the glycocalyx also affected clustering; high affinity interactions
coupled with thinner glycocalyx resulted in bound integrin recep-
tors with minimal clustering. A thicker glycocalyx relative to inte-
grin bond length, along with an adequate receptor–ligand affinity,
resulted in both integrin binding and clustering. Integrin cluster-
ing increased due to increases in the ratio of glycocalyx stiffness
to membrane stiffness, as it increased the minimal matrix ligand
density. Integrin clustering was shown to be sensitive to ECM stiff-
ness; compliant substrates could not promote cooperative binding,
while integrin clustering increased with increasing substrate stiff-
ness above 2000 Pa. While the computational model only incorpo-
rates basic biology, a combination of the mechanical model with
molecular interactions revealed cell adhesion behavior observed
in experiments (Cluzel et al., 2005; Paszek et al., 2009). Future
models should focus on the incorporation of applied fluid shear
forces, along with integrin–cytoskeleton interactions, to predict
how adhesions on the cancer cell surface can sense and respond to
the tumor microenvironment.
CONCLUSION
Fluid shear stresses generated by blood and interstitial flows alter
cancer cell behavior in the vascular and tumor microenviron-
ments, respectively, and contribute to the progression of cancer
metastasis. Interstitial flow-generated forces elevate tumor IFP,and
create challenges to chemotherapeutic delivery to the tumor inte-
rior. Such forces also induce phenotypic changes of cells in the sur-
rounding microenvironment, which enhance tumor cell migration
and invasion. Shear flows in the circulation affect tumor cell viabil-
ity while also playing a role in CTC adhesion to the endothelium, a
crucial step for subsequent tumor cell extravasation and metasta-
sis. Recent experimental studies have revealed that fluid shear stress
can modulate intrinsic characteristics of cells, in addition to the
extrinsic roles of fluid flow that have been previously documented.
Cancer cell mechanotransduction observed in recent experiments,
including tumor cell resistance to shear stress, regulation of migra-
tion and invasion, and sensitivity to chemotherapeutics, have
potentially wide ranging implications for metastasis. Recent com-
putational models have incorporated mechanical fluid forces with
chemical signaling networks, along with mechanotransducing
components on the cancer cell surface, such as the glycocalyx.
Future approaches utilizing computational models of fluid shear
stress effects on intrinsic tumor cell signaling networks, coupled
with in vitro and in vivo experimental validation, may better pre-
dict cell behavior in such dynamic microenvironments, and poten-
tially provide novel approaches for the prevention of metastasis.
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